FR3587M - Nouvelle composition anti-asthmatique. - Google Patents
Nouvelle composition anti-asthmatique.Info
- Publication number
- FR3587M FR3587M FR984004A FR984004A FR3587M FR 3587 M FR3587 M FR 3587M FR 984004 A FR984004 A FR 984004A FR 984004 A FR984004 A FR 984004A FR 3587 M FR3587 M FR 3587M
- Authority
- FR
- France
- Prior art keywords
- ephedrine
- theophylline
- bromelain
- enzyme
- calcium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000203 mixture Substances 0.000 title abstract 5
- 230000001088 anti-asthma Effects 0.000 title 1
- 239000000924 antiasthmatic agent Substances 0.000 title 1
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 abstract 4
- CAVQBDOACNULDN-KHFUBBAMSA-N (1r,2s)-2-(methylamino)-1-phenylpropan-1-ol;sulfuric acid Chemical compound OS(O)(=O)=O.CN[C@@H](C)[C@H](O)C1=CC=CC=C1.CN[C@@H](C)[C@H](O)C1=CC=CC=C1 CAVQBDOACNULDN-KHFUBBAMSA-N 0.000 abstract 2
- 108010004032 Bromelains Proteins 0.000 abstract 2
- 108090000790 Enzymes Proteins 0.000 abstract 2
- 102000004190 Enzymes Human genes 0.000 abstract 2
- 239000004365 Protease Substances 0.000 abstract 2
- VIROVYVQCGLCII-UHFFFAOYSA-N amobarbital Chemical compound CC(C)CCC1(CC)C(=O)NC(=O)NC1=O VIROVYVQCGLCII-UHFFFAOYSA-N 0.000 abstract 2
- 235000019835 bromelain Nutrition 0.000 abstract 2
- ZRIHAIZYIMGOAB-UHFFFAOYSA-N butabarbital Chemical compound CCC(C)C1(CC)C(=O)NC(=O)NC1=O ZRIHAIZYIMGOAB-UHFFFAOYSA-N 0.000 abstract 2
- 229940088598 enzyme Drugs 0.000 abstract 2
- 229960002179 ephedrine Drugs 0.000 abstract 2
- YAPQBXQYLJRXSA-UHFFFAOYSA-N theobromine Chemical compound CN1C(=O)NC(=O)C2=C1N=CN2C YAPQBXQYLJRXSA-UHFFFAOYSA-N 0.000 abstract 2
- 229960000278 theophylline Drugs 0.000 abstract 2
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 abstract 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 1
- 229920000623 Cellulose acetate phthalate Polymers 0.000 abstract 1
- 108090000317 Chymotrypsin Proteins 0.000 abstract 1
- OCUCCJIRFHNWBP-IYEMJOQQSA-L Copper gluconate Chemical class [Cu+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OCUCCJIRFHNWBP-IYEMJOQQSA-L 0.000 abstract 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 abstract 1
- HLCFGWHYROZGBI-JJKGCWMISA-M Potassium gluconate Chemical compound [K+].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O HLCFGWHYROZGBI-JJKGCWMISA-M 0.000 abstract 1
- 229920001800 Shellac Polymers 0.000 abstract 1
- 108090000631 Trypsin Proteins 0.000 abstract 1
- 102000004142 Trypsin Human genes 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 229960003556 aminophylline Drugs 0.000 abstract 1
- FQPFAHBPWDRTLU-UHFFFAOYSA-N aminophylline Chemical compound NCCN.O=C1N(C)C(=O)N(C)C2=C1NC=N2.O=C1N(C)C(=O)N(C)C2=C1NC=N2 FQPFAHBPWDRTLU-UHFFFAOYSA-N 0.000 abstract 1
- 229960001301 amobarbital Drugs 0.000 abstract 1
- 229940015694 butabarbital Drugs 0.000 abstract 1
- 239000011575 calcium Substances 0.000 abstract 1
- 229910052791 calcium Inorganic materials 0.000 abstract 1
- 235000001465 calcium Nutrition 0.000 abstract 1
- 235000013921 calcium diglutamate Nutrition 0.000 abstract 1
- UMVAYAXXQSFULN-QHTZZOMLSA-L calcium;(2s)-2-aminopentanedioate;hydron Chemical compound [Ca+2].[O-]C(=O)[C@@H](N)CCC(O)=O.[O-]C(=O)[C@@H](N)CCC(O)=O UMVAYAXXQSFULN-QHTZZOMLSA-L 0.000 abstract 1
- 239000000969 carrier Substances 0.000 abstract 1
- 229940081734 cellulose acetate phthalate Drugs 0.000 abstract 1
- 229960002376 chymotrypsin Drugs 0.000 abstract 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 239000002702 enteric coating Substances 0.000 abstract 1
- 238000009505 enteric coating Methods 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 239000007942 layered tablet Substances 0.000 abstract 1
- ALARQZQTBTVLJV-UHFFFAOYSA-N mephobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)N(C)C1=O ALARQZQTBTVLJV-UHFFFAOYSA-N 0.000 abstract 1
- 229960001703 methylphenobarbital Drugs 0.000 abstract 1
- 235000013919 monopotassium glutamate Nutrition 0.000 abstract 1
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 229960002695 phenobarbital Drugs 0.000 abstract 1
- DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 abstract 1
- 229960003975 potassium Drugs 0.000 abstract 1
- 239000011591 potassium Substances 0.000 abstract 1
- 229910052700 potassium Inorganic materials 0.000 abstract 1
- 229960003189 potassium gluconate Drugs 0.000 abstract 1
- 235000013926 potassium gluconate Nutrition 0.000 abstract 1
- 239000004224 potassium gluconate Substances 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- KWGRBVOPPLSCSI-WCBMZHEXSA-N pseudoephedrine Chemical compound CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WCBMZHEXSA-N 0.000 abstract 1
- 229960003908 pseudoephedrine Drugs 0.000 abstract 1
- 229950003070 racephedrine Drugs 0.000 abstract 1
- 208000023504 respiratory system disease Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229940113147 shellac Drugs 0.000 abstract 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 abstract 1
- 235000013874 shellac Nutrition 0.000 abstract 1
- 239000004208 shellac Substances 0.000 abstract 1
- 239000002278 tabletting lubricant Substances 0.000 abstract 1
- 229960004559 theobromine Drugs 0.000 abstract 1
- 239000012588 trypsin Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US351522A US3287220A (en) | 1964-03-12 | 1964-03-12 | Anti-asthmatic composition and methods |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FR3587M true FR3587M (fr) | 1965-10-04 |
Family
ID=23381269
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR984004A Expired FR3587M (fr) | 1964-03-12 | 1964-08-03 | Nouvelle composition anti-asthmatique. |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US3287220A (fr) |
| DE (1) | DE1492104A1 (fr) |
| FR (1) | FR3587M (fr) |
| GB (1) | GB1056116A (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3928567A (en) * | 1974-08-26 | 1975-12-23 | Ariel A Andersen | Dietary supplement |
| US4062937A (en) * | 1976-03-12 | 1977-12-13 | La Verne Rea | Insect bite relief preparation |
| GB8426275D0 (en) * | 1984-10-17 | 1984-11-21 | Fisher R | Weight control |
| US6458384B2 (en) | 2000-02-23 | 2002-10-01 | Impetus Ag | Pharmaceutical with predetermined activity profile |
-
1964
- 1964-03-12 US US351522A patent/US3287220A/en not_active Expired - Lifetime
- 1964-08-03 FR FR984004A patent/FR3587M/fr not_active Expired
- 1964-08-14 GB GB33337/64A patent/GB1056116A/en not_active Expired
- 1964-08-19 DE DE19641492104 patent/DE1492104A1/de active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DE1492104A1 (de) | 1969-07-17 |
| GB1056116A (en) | 1967-01-25 |
| US3287220A (en) | 1966-11-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO145883C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 7-methoxy-7-acylamino-cefalosporansyrederivater | |
| GB984464A (en) | Therapeutic compositions comprising bromelain | |
| SE8400332D0 (sv) | Forening for anvendning som mellanprodukt vid framstellning av lekemedel | |
| FR3587M (fr) | Nouvelle composition anti-asthmatique. | |
| US2373763A (en) | Enteric coating | |
| NO137899C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive n (1h-tetrazol-5-yl)-kinaldamider | |
| Beaumont et al. | The renal function in myxoedema | |
| GB1302266A (fr) | ||
| US3121044A (en) | Three-layer compressed penicillin tablet | |
| GB1033843A (en) | Pharmaceutical composition for treating thermatoid arthritis | |
| ZA724724B (en) | Pharmaceutical compositions for treatment of bronchial diseases | |
| GB1118606A (en) | Compositions for the treatment of haemorrhoids | |
| Hare et al. | Acrodermatitis enteropathica | |
| IE36780L (en) | Pharmaceutical preparations | |
| GB976096A (en) | Pharmaceutical compositions | |
| GB923076A (en) | Antiprotozoal pharmaceutical preparations and the manufacture thereof | |
| GB1036059A (en) | Improvements in or relating to the inhibition of bacterial growth | |
| LAZAR et al. | Streptococcal Disease and Rheumatic Fever in Air Force Recruits: I. Epidemiology and Clinical Picture of Acute Rheumatic Fever | |
| GR33412B (el) | Μεθοδος παρασκευης φαρμακευτικων συνθεσεων δια την θεραπειαν τησαθηροσκληρωσεως, αρτηριοσκληρυνσεωσκαι συγγενων μεταβολικων ασθενειων. | |
| GB1287433A (en) | Pharmaceutical compositions | |
| Walker et al. | OT CHIRP: A method of early assignment of hospital psychiatric patients to paid work. | |
| CA503996A (fr) | Composition pharmaceutique pour usage dans le traitement de keratine | |
| AU154041B2 (en) | Composition forthe curative treatment of foot rot | |
| JPS61502395A (ja) | 単純ヘルパスの治療 | |
| AU116962B2 (en) | Improved method of curative treatment of sheep affected by blowfly and to prevent recurrence ofthe disease |